​

1.  Bagga, Paramjeet. “What Is Bioinformatics?” Ramapo Bioinformatics, Ramapo College of 

         New Jersey, 2020,https://bioinformatics.ramapo.edu/what/index.html.
 

2. Bayat, Ardeshir. “Science, medicine, and the future: Bioinformatics.” BMJ (Clinical research 

ed.) vol. 324,7344 (2002): 1018-22. doi:10.1136/bmj.324.7344.1018

​

3. Pongor, Sándor, and David Landsman. “Bioinformatics and the developing world.” 

Biotechnology and development monitor vol. 40 (1999): 10-13. 

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4422384/

​

4. “ACE2 Angiotensin I Converting Enzyme 2 [ Homo Sapiens (Human) ].” National Center for 

Biotechnology, 13 Dec. 2020, www.ncbi.nlm.nih.gov/gene/59272.

 

5. “Homo sapiens chromosome X, GRCh38.p13 Primary Assembly”. NCBI,

https://www.ncbi.nlm.nih.gov/nuccore/NC_000023.11?report=genbank&from=15518197

&to=15602158&strand=true

 

6.  “Homo sapiens angiotensin I converting enzyme 2 (ACE2), RefSeqGene on chromosome X”. 

NCBI, https://www.ncbi.nlm.nih.gov/nuccore/1890603762.

 

7. “Homo sapiens angiotensin I converting enzyme 2 (ACE2), transcript variant 2, mRNA”. 

NCBI, https://www.ncbi.nlm.nih.gov/nuccore/NM_021804.3.

 

8. “angiotensin-converting enzyme 2 isoform 1 precursor [Homo sapiens]”. NCBI, 

https://www.ncbi.nlm.nih.gov/protein/NP_068576.1.

 

9. “Homo sapiens angiotensin I converting enzyme 2 (ACE2), transcript variant 5, mRNA”. 

NCBI, https://www.ncbi.nlm.nih.gov/nuccore/NM_001388452.1.

 

10. “Homo sapiens angiotensin I converting enzyme 2 (ACE2), transcript variant 4, mRNA”. 

NCBI, https://www.ncbi.nlm.nih.gov/nuccore/NM_001386260.1.

 

11. “ACE2_1 In Humans.” Eukaryotic Promoter Database, EPD, Oct. 2019, 

epd.epfl.ch/cgi-bin/get_doc?db=hgEpdNew.

 

12.  “ACE2_2 In Humans.” Eukaryotic Promoter Database, EDP, Oct. 2019, 

epd.epfl.ch/cgi-bin/get_doc?db=hgEpdNew.

 

13. Onabajo, O.O., Banday, A.R., Stanifer, M.L. et al. Interferons and viruses induce a novel 

truncated ACE2 isoform and not the full-length SARS-CoV-2 receptor. Nat Genet 52, 

1283–1293 (2020). https://doi.org/10.1038/s41588-020-00731-9

 

14. (Uniprot struc/main)

“UniProtKB - Q9BYF1 (ACE2_HUMAN).” UniProt, https://www.uniprot.org/uniprot/Q9BYF1

 

15. “Gene: ACE2”, Ensembl, 

https://useast.ensembl.org/Homo_sapiens/Gene/Summary?db=core;g=ENSG0000013023

4;r=X:15494566-15607236

​

16. Hamming, I et al. “Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. 

A first step in understanding SARS pathogenesis.” The Journal of pathology vol. 203,2 (2004): 

631-7. doi:10.1002/path.1570.

 

17. Cerdà-Costa, Núria, and Francesc Xavier Gomis-Rüth. “Architecture and Function of Metallopeptidase Catalytic 

Domains.” Protein Science : a Publication of the Protein Society, Blackwell Publishing Ltd, Feb. 2014, 

www.ncbi.nlm.nih.gov/pmc/articles/PMC3926739/.

 

18. NCBI. “AceView: Gene:, a Comprehensive Annotation of Human, Mouse and Worm Genes with MRNAs or 

ESTsAceView.” National Center for Biotechnology Information, U.S. National Library of Medicine, 2010, 

www.ncbi.nlm.nih.gov/IEB/Research/Acembly/av.cgi?db=human.

 

19. “7A98: SARS-CoV-2 Spike Glycoprotein with 3 ACE2 Bound.” National Center for 

Biotechnology Information, U.S. National Library of Medicine, www.ncbi.nlm.nih.gov/Structure/pdb/7A98.

 

20. “angiotensin-converting enzyme 2 isoform 1 precursor [Homo sapiens]”. NCBI, https://www.ncbi.nlm.nih.gov/protein

/NP_001358344.1.

 

21. Macours, Nathalie et al. “Structure, evolutionary conservation, and functions of angiotensin- 

and endothelin-converting enzymes.” International review of cytology vol. 239 (2004): 47-97. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7126198/.

​

22. “ANGIOTENSIN I-CONVERTING ENZYME 2; ACE2”. OMIM, 

https://omim.org/entry/300335.

 

23. Staker, Bart, et al. “ACE2 X-Ray Structures Reveal a Large Hinge-bending Motion 

Important for Inhibitor Binding and Catalysis.” The Journal of Biological Chemistry 

Vol.279 (2004):17996–18007.https://www.researchgate.net/publication/8892853_ACE2_X-Ray_Structures_Reveal_a_Large_Hinge-bending_Motion_Important_for_Inhibitor_Binding_and_Catalysis.

 

24. Bian, Jingwei, and Li, Zijian. “Angiotensin-converting enzyme 2 (ACE2): SARS-CoV-2 

receptor and RAS modulator.” Acta Pharmaceutica Sinica B. (2020). https://doi.org/10.1016/j.apsb.2020.10.006.

 

25. Cerdà-Costa, Núria, and Francesc Xavier Gomis-Rüth. “Architecture and function of 

metallopeptidase catalytic domains.” Protein science : a publication of the Protein Society vol. 23,2 (2014): 123-44. Doi: 10.1002/pro.2400.

 

26. “UniProtKB - Q9HBJ8  (CLTRN_HUMAN).” UniProt, https://www.uniprot.org/uniprot/Q9HBJ8.

 

27. Zhang, Yanling, and Wada, Jun. “Collectrin, a homologue of ACE2, its transcriptional control and functional perspectives.”

Biochemical and Biophysical Research Communications vol 363. 1,9 (2007): 1-5. https://doi.org/10.1016/j.bbrc.2007.08.136.

 

28. “Angiotensin Converting Enzyme 2”. Science Direct, https://www.sciencedirect.com/topics/pharmacology-toxicology-and-

pharmaceutical-science/angiotensin-converting-enzyme-2. 

 

29. “ACE2 angiotensin I converting enzyme 2 [ Homo sapiens (human)]”. NCBI, https://www.ncbi.nlm.nih.gov/gene/59272.

 

30. “Angiotensin-converting enzyme 2”. AMiGO 2, http://amigo.geneontology.org/amigo/gene_product/UniProtKB:Q9BYF1.

​

31. Abd El-Aziz, T.M., Al-Sabi, A. & Stockand, J.D. “Human recombinant soluble ACE2 (hrsACE2) shows promise for treating

severe COVID­19.” Sig Transduct Target Ther 5, 258 (2020). https://doi.org/10.1038/s41392-020-00374-6.

 

32. Burrell, Louise M et al. “ACE2, a new regulator of the renin-angiotensin system.” Trends in endocrinology and metabolism:

TEM vol. 15,4 (2004): 166-9. doi:10.1016/j.tem.2004.03.001.

 

33. Perlot, Thomas, and Penninger, Josef M. “ACE2 – From the renin–angiotensin system to gut microbiota and malnutrition”

vol. 15, 13 (2013): 866-873. https://doi.org/10.1016/j.micinf.2013.08.003.

 

34. “ACE2 Gene”. GeneCards The Human Gene Database, https://www.genecards.org/cgi-bin/carddisp.pl?gene=ACE2.

 

35. “Peptidase_M2.” Conserved Domains Database. 

https://www.ncbi.nlm.nih.gov/Structure/cdd/cddsrv.cgi?ascbin=8&maxaln=10&seltype=2&uid=pfam01401.

 

36. “Renin-angiotensin system - Homo sapiens (human)”. KEGG, 

https://www.kegg.jp/kegg-bin/show_pathway?hsa04614.

 

37. Fountain JH, Lappin SL. “Physiology, Renin Angiotensin System.” StatPearls Publishing (2020), 

https://www.ncbi.nlm.nih.gov/books/NBK470410/.

 

38. Boopathi, Subramanian et al. “Novel 2019 coronavirus structure, mechanism of action, antiviral drug promises and rule out

against its treatment.” Journal of biomolecular structure & dynamics, 1-10. 30 Apr. 2020, 

Doi: 10.1080/07391102.2020.1758788.

 

39. Astuti, Indwiani, and Ysrafil. “Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An overview of viral structure

and host response.” Diabetes & metabolic syndrome vol. 14,4 (2020): 407-412. 

doi:10.1016/j.dsx.2020.04.020.

 

40. “Homo sapiens complex locus ACE2, encoding angiotensin I converting enzyme (peptidyl-dipeptidase A) 2,”. NCBI, 

https://www.ncbi.nlm.nih.gov/IEB/Research/Acembly/av.cgi?db=human&term=ace2&submit=Go.

 

41. “Gene: ACE2 - ENSG00000130234 - Homo sapiens (human)”. Bgee, https://bgee.org/?

page=gene&gene_id=ENSG00000130234.

 

42. Hamming, I et al. “Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in

understanding SARS pathogenesis.” The Journal of pathology vol. 203,2 (2004): 631-7. Doi: 10.1002/path.1570

​

43. “UniProtKB - P01019 (ANGT_HUMAN)”. UniProt, https://www.uniprot.org/uniprot/P01019.

 

44. “Neurotensin”. ScienceDirect, 

https://www.sciencedirect.com/topics/neuroscience/neurotensin#:~:text=Neurotensin%20

also%20inhibits%20postprandial%20gastric,histamine%20release%20from%20mast%20cells.

​

45. “UniProtKB - P30990 (NEUT_HUMAN)”. UniProt, https://www.uniprot.org/uniprot/P30990.

​

46. “UniProtKB - P04040 (CATA_HUMAN)”. UniProt, https://www.uniprot.org/uniprot/P04040#function.

 

47. Foussal, Camille, et al. “Activation of catalase by apelin prevents oxidative stress-linked 

cardiac hypertrophy”. FEBS Letters vol. 584, 3 (2010: 2363-2370. https://doi.org/10.1016/j.febslet.2010.04.025.

​

48. “UniProtKB - P0DTC2 (SPIKE_SARS2)”. UniProt, https://www.uniprot.org/uniprot/P0DTC2#PRO_0000449647. 

 

49. “UniProtKB - P59594 (SPIKE_SARS).” UniProt, https://www.uniprot.org/uniprot/P59594.

 

50. “kininogen-1 isoform 1 precursor [Homo sapiens],” NCBI, https://www.ncbi.nlm.nih.gov/protein/NP_001095886.1.

​

51. Jo, Bong-Seok, and Sun Shim Choi. “Introns: The Functional Benefits of Introns in Genomes.” Genomics &

informatics vol. 13,4 (2015): 112-8. doi:10.5808/GI.2015.13.4.112

 

52. Hamid Hadi-Alijanvand and Maryam RouhaniJournal of Proteome Research 2020 19 (11), 4609-4623

https://doi.org/10.1021/acs.jproteome.0c00348

​

53. Hou, Y., Zhao, J., Martin, W. et al. New insights into genetic susceptibility of COVID-19: an ACE2 and TMPRSS2

polymorphism analysis. BMC Med 18, 216 (2020). https://doi.org/10.1186/s12916-020-01673-z

 

54. Pacholczyk, Marta et al. “Association of angiotensin-converting enzyme and angiotensin II type I receptor gene

polymorphisms with extreme obesity in Polish individuals.” DNA and cell biology vol. 32,8 (2013): 435-42. doig:10.1089/dna.2013.2014

 

55. Liu, Cheng et al. “ACE2 polymorphisms associated with cardiovascular risk in Uygurs with type 2 diabetes mellitus.”

Cardiovascular diabetology vol. 17,1 127. 18 Sep. 2018, doi:10.1186/s12933-018-0771-3

 

56. Wang SX, Fu CY, Zou YB, Wang H, Shi Y, Xu XQ, Chen JZ, Song XD, Huan TJ, Hui RT. 

Polymorphisms of angiotensin-converting enzyme 2 gene associated with magnitude of 

left ventricular hypertrophy in male patients with hypertrophic cardiomyopathy. Chin Med J (Engl). 2008 Jan 5;121(1):27-31. PMID: 18208662. https://pubmed.ncbi.nlm.nih.gov/18208662/

 

57. Wang, Wang et al. “Heterozygote loss of ACE2 is sufficient to increase the susceptibility to 

heart disease.” Journal of molecular medicine (Berlin, Germany) vol. 92,8 (2014): 

847-58. doi:10.1007/s00109-014-1149-y

​

58. He, Jing et al. “Fetal But Not Maternal Angiotensin Converting Enzyme (ACE)-2 Gene 

Rs2074192 Polymorphism is Associated with Increased Risk of Being a Small For 

Gestational Age (SGA) Newborn.” Kidney & blood pressure research vol. 43,5 (2018): 1596-1606. doi:10.1159/000494449

 

59. Mayo Clinic Staff. “Coronavirus Disease 2019 (COVID-19).” Mayo Clinic, Mayo 

Foundation for Medical Education and Research, 24 Nov. 2020, 

www.mayoclinic.org/diseases-conditions/coronavirus/symptoms-causes/syc-20479963.

​

60. Tang D, Comish P, Kang R (2020) The hallmarks of COVID-19 disease. PLOS Pathogens 

16(5): e1008536. https://doi.org/10.1371/journal.ppat.1008536

 

61. Ali, Mukarram Jamat et al. “Treatment Options for COVID-19: A Review.” Frontiers in 

medicine vol. 7 480. 31 Jul. 2020, doi: 10.3389/fmed.2020.00480.

​

62. Mayo Clinic Staff. “High Blood Pressure (Hypertension).” Mayo Clinic, Mayo Foundation 

for Medical Education and Research, 12 May 2018, www.mayoclinic.org/diseases-conditions/high-blood-pressure/symptoms-causes/syc-20373410.

​

63. D’Ardes, Damiano et al. “COVID-19 and RAS: Unravelling an Unclear Relationship.” 

International Journal of Molecular Sciences 21.8 (2020):http://dx.doi.org/10.3390/ijms21083003.

​

64. Schulze-Neick, I., and M. Beghetti. “Issues Related to the Management and Therapy of 

Paediatric Pulmonary Hypertension.” European Respiratory Society, European 

Respiratory Society, 1 Dec. 2010, https://err.ersjournals.com/content/19/118/331.figures-only

 

65. Federico, Cacciapuoti. “Natriuretic Peptide system and cardiovascular disease.” Heart views 

: the official journal of the Gulf Heart Association vol. 11,1 (2010): 10-5. 

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2964706/

​

66. Oparil S, Schmieder RE. New approaches in the treatment of hypertension. Circ Res. 2015 

Mar 13;116(6):1074-95. doi: 10.1161/CIRCRESAHA.116.303603. PMID: 25767291

 

67. “Hypertension: MedlinePlus Genetics.” MedlinePlus, U.S. National Library of Medicine, 18 

Aug. 2020, medlineplus.gov/genetics/condition/hypertension/

 

68.  NM, Ratan. "ACE Inhibitors: Mechanism of Action, Side Effects and Precautions". 

News-Medical. 15 December 2020. <https://www.news-medical.net/health/ACE-Inhibitors-Mechanism-of-Action-Side-Effects-and-Precautions.aspx>.

 

69. “Types of Blood Pressure Medications.” Heart.org, American Heart Association, 31 Oct. 

2017,www.heart.org/en/health-topics/high-blood-pressure/changes-you-can-make-to-manage-high-blood-pressure/types-of-blood-pressure-medications.

 

70. Schulze-Neick, I., and M. Beghetti. “Issues Related to the Management and Therapy of Paediatric Pulmonary

Hypertension.” European Respiratory Society, European Respiratory Society, 1 Dec. 2010, DOI:10.1183/09059180.00008510.